Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | nitric oxide synthase, putative | 0.0546 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0209 | 0.3655 | 0.5 |
Schistosoma mansoni | cytochrome B5 | 0.0062 | 0.0892 | 0.0669 |
Chlamydia trachomatis | sulfite reductase | 0.0337 | 0.6069 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0546 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0546 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.023 | 0.023 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0546 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0337 | 0.6069 | 0.5973 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0546 | 1 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0484 | 0.8832 | 0.8717 |
Echinococcus multilocularis | cytochrome b5 reductase 4 | 0.0062 | 0.0892 | 0.0669 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0484 | 0.8832 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.0239 | 0.0239 |
Trypanosoma cruzi | p450 reductase, putative | 0.0546 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0209 | 0.3655 | 0.5 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0209 | 0.3655 | 0.3033 |
Echinococcus multilocularis | NADH cytochrome b5 reductase 3 | 0.0062 | 0.0892 | 0.0669 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0546 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0546 | 1 | 1 |
Mycobacterium tuberculosis | Possible oxygenase | 0.0062 | 0.0892 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0546 | 1 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0546 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0546 | 1 | 1 |
Brugia malayi | flavodoxin family protein | 0.0209 | 0.3655 | 0.3655 |
Brugia malayi | diaphorase | 0.0062 | 0.0892 | 0.0892 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.0062 | 0.0892 | 0.0669 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.0239 | 0.0239 |
Brugia malayi | FAD binding domain containing protein | 0.0546 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0546 | 1 | 1 |
Treponema pallidum | flavodoxin | 0.0209 | 0.3655 | 1 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.0062 | 0.0892 | 0.5 |
Echinococcus granulosus | NADH cytochrome b5 reductase 3 | 0.0062 | 0.0892 | 0.0669 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0062 | 0.0892 | 0.5 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0484 | 0.8832 | 0.8159 |
Giardia lamblia | Hypothetical protein | 0.0484 | 0.8832 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0546 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0546 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0271 | 0.4823 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0546 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0337 | 0.6069 | 0.5973 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0209 | 0.3655 | 0.3033 |
Leishmania major | hypothetical protein, conserved | 0.0209 | 0.3655 | 0.3033 |
Echinococcus granulosus | methionine synthase reductase | 0.0337 | 0.6069 | 0.5973 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.0062 | 0.0892 | 0.5 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0209 | 0.3655 | 0.3033 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0062 | 0.0892 | 0.0892 |
Plasmodium vivax | hypothetical protein, conserved | 0.0209 | 0.3655 | 0.3033 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0546 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0337 | 0.6069 | 0.6069 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.0062 | 0.0892 | 0.0669 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0062 | 0.0892 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0027 | 0.0239 | 0.0239 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0209 | 0.3655 | 0.3655 |
Loa Loa (eye worm) | diaphorase | 0.0062 | 0.0892 | 0.0892 |
Leishmania major | cytochrome P450 reductase, putative | 0.0484 | 0.8832 | 0.8717 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0239 | 0.0239 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.0239 | 0.0239 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0062 | 0.0892 | 0.0892 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0209 | 0.3655 | 0.3033 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0546 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0546 | 1 | 1 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0209 | 0.3655 | 0.3033 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0275 | 0.4901 | 0.4776 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0271 | 0.4823 | 0.4696 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0209 | 0.3655 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0209 | 0.3655 | 0.5 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0209 | 0.3655 | 0.3033 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0546 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0271 | 0.4823 | 1 |
Onchocerca volvulus | 0.0062 | 0.0892 | 1 | |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0546 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0546 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0337 | 0.6069 | 0.6069 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0209 | 0.3655 | 0.5 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.0062 | 0.0892 | 0.0669 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.